Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot.

Powell WE, Hanna SJ, Hocter CN, Robinson E, Lewis M, Dunseath G, Luzio S, Howell A, Dayan CM, Wong FS.

J Immunol Methods. 2019 Aug;471:61-65. doi: 10.1016/j.jim.2019.05.007. Epub 2019 May 29.

PMID:
31152768
2.

Performance evaluation of a self-administered home oral glucose tolerance test kit in a controlled clinical research setting.

Dunseath GJ, Bright D, Jones C, Dowrick S, Cheung WY, Luzio SD.

Diabet Med. 2019 Jul;36(7):862-867. doi: 10.1111/dme.13961. Epub 2019 Apr 26.

PMID:
30972793
3.
4.

Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems.

Dunseath GJ, Bright D, Luzio SD.

J Diabetes Sci Technol. 2019 May;13(3):568-574. doi: 10.1177/1932296818821389. Epub 2019 Jan 9.

PMID:
30623673
5.

Haemodiafiltration use in children: data from the Italian Pediatric Dialysis Registry.

Paglialonga F, Vidal E, Pecoraro C, Guzzo I, Giordano M, Gianoglio B, Corrado C, Roperto R, Ratsch I, Luzio S, Murer L, Consolo S, Pieri G, Montini G, Edefonti A, Verrina E.

Pediatr Nephrol. 2019 Jun;34(6):1057-1063. doi: 10.1007/s00467-018-4184-z. Epub 2019 Jan 5.

PMID:
30612203
6.

Utility of HbA1c assessment in people with diabetes awaiting liver transplantation.

Bhattacharjee D, Vracar S, Round RA, Nightingale PG, Williams JA, Gkoutos GV, Stratton IM, Parker R, Luzio SD, Webber J, Manley SE, Roberts GA, Ghosh S.

Diabet Med. 2018 Nov 26. doi: 10.1111/dme.13870. [Epub ahead of print]

PMID:
30474191
7.

Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study.

Peter R, Bright D, Cheung WY, Luzio SD, Dunseath GJ.

BMJ Open. 2018 Aug 29;8(8):e022571. doi: 10.1136/bmjopen-2018-022571.

8.

Uniform sensing layer of immiscible enzyme-mediator compounds developed via a spray aerosol mixing technique towards low cost minimally invasive microneedle continuous glucose monitoring devices.

Samavat S, Lloyd J, O'Dea L, Zhang W, Preedy E, Luzio S, Teng KS.

Biosens Bioelectron. 2018 Oct 30;118:224-230. doi: 10.1016/j.bios.2018.07.054. Epub 2018 Jul 27.

PMID:
30092458
9.

Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes.

Powell WE, Hanna SJ, Hocter CN, Robinson E, Davies J, Dunseath GJ, Luzio S, Farewell D, Wen L, Dayan CM, Price DA, Ladell K, Wong FS.

Diabetologia. 2018 Aug;61(8):1794-1803. doi: 10.1007/s00125-018-4651-x. Epub 2018 Jun 7.

10.

Microsampling Collection Methods for Measurement of C-peptide in Whole Blood.

Jones C, Dunseath GJ, Lemon J, Luzio SD.

J Diabetes Sci Technol. 2018 Sep;12(5):1024-1028. doi: 10.1177/1932296818763464. Epub 2018 Mar 9.

11.

Stability of proinsulin in whole blood.

Bright DJ, Dunseath GJ, Peter R, Luzio S.

Clin Biochem. 2018 Feb;52:153-155. doi: 10.1016/j.clinbiochem.2017.10.005. Epub 2017 Oct 16.

PMID:
29051035
12.

Comparison of a point-of-care analyser for the determination of HbA1c with HPLC method.

Grant DA, Dunseath GJ, Churm R, Luzio SD.

Pract Lab Med. 2017 Apr 4;8:26-29. doi: 10.1016/j.plabm.2017.04.001. eCollection 2017 Aug.

13.

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.

Alhadj Ali M, Liu YF, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, Heck S, Yang JHM, Tree TIM, Pujol-Autonell I, Yeo L, Baumard LR, Stenson R, Howell A, Clark A, Boult Z, Powrie J, Adams L, Wong FS, Luzio S, Dunseath G, Green K, O'Keefe A, Bayly G, Thorogood N, Andrews R, Leech N, Joseph F, Nair S, Seal S, Cheung H, Beam C, Hills R, Peakman M, Dayan CM.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaaf7779. doi: 10.1126/scitranslmed.aaf7779.

PMID:
28794283
14.

Accuracy Evaluation of a Blood Glucose Monitoring System According to EN ISO 15197:2015.

Bright D, Dunseath G, Berti F, Scuffi C, Valgimigli F, Luzio S.

J Diabetes Sci Technol. 2017 Jul;11(4):849-850. doi: 10.1177/1932296817695340. Epub 2017 Feb 1. No abstract available.

15.

Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015.

Thomas RL, Luzio SD, North RV, Banerjee S, Zekite A, Bunce C, Owens DR.

BMJ Open. 2017 Jul 18;7(7):e015024. doi: 10.1136/bmjopen-2016-015024.

16.

Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.

Parsons S, Luzio S, Bain S, Harvey J, McKenna J, Khan A, Rice S, Watkins A, Owens DR.

BMC Endocr Disord. 2017 Jan 26;17(1):4. doi: 10.1186/s12902-017-0154-x.

17.

Stimulated urine C-peptide creatinine ratio vs serum C-peptide level for monitoring of β-cell function in the first year after diagnosis of Type 1 diabetes.

Tatovic D, Luzio S, Dunseath G, Liu Y, Alhadj Ali M, Peakman M, Dayan CM; MonoPepT1De Study Group.

Diabet Med. 2016 Nov;33(11):1564-1568. doi: 10.1111/dme.13186. Epub 2016 Aug 8.

PMID:
27425010
18.

Postmarket Approval Surveillance of a Low Acquisition Cost Blood Glucose Monitoring System: Assessment of the Accuracy Following ISO 15197:2013.

Grant DA, Dunseath GJ, Bain SC, Luzio S.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1195-6. doi: 10.1177/1932296816648991. Print 2016 Sep. No abstract available.

19.

Can HbA1c detect undiagnosed diabetes in acute medical hospital admissions?

Manley SE, O'Brien KT, Quinlan D, Round RA, Nightingale PG, Ali F, Durrani BK, Liew A, Luzio SD, Stratton IM, Roberts GA.

Diabetes Res Clin Pract. 2016 May;115:106-14. doi: 10.1016/j.diabres.2016.01.023. Epub 2016 Jan 21.

PMID:
27012459
20.

HbA1c measurement and relationship to incident stroke.

Robson R, Lacey AS, Luzio SD, Van Woerden H, Heaven ML, Wani M, Halcox JP, Castilla-Guerra L, Dawson J, Hewitt J.

Diabet Med. 2016 Apr;33(4):459-62. doi: 10.1111/dme.13057. Epub 2016 Jan 18.

21.

Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.

Roy Chowdhury S, Thomas RL, Dunseath GJ, Peter R, Rees DA, North RV, Luzio SD, Owens DR.

J Clin Endocrinol Metab. 2016 Feb;101(2):572-80. doi: 10.1210/jc.2015-2203. Epub 2015 Dec 11.

PMID:
26652932
22.

Design and In Vitro Interference Test of Microwave Noninvasive Blood Glucose Monitoring Sensor.

Choi H, Naylon J, Luzio S, Beutler J, Birchall J, Martin C, Porch A.

IEEE Trans Microw Theory Tech. 2015 Oct 1;63(10 Pt 1):3016-3025.

23.

Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery.

Mallipedhi A, Min T, Prior SL, MacIver C, Luzio SD, Dunseath G, Bracken RM, Islam S, Barry JD, Caplin S, Stephens JW.

Metabolism. 2015 Nov;64(11):1556-63. doi: 10.1016/j.metabol.2015.08.009. Epub 2015 Aug 18.

PMID:
26386694
24.

Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.

Turner D, Luzio S, Gray BJ, Bain SC, Hanley S, Richards A, Rhydderch DC, Martin R, Campbell MD, Kilduff LP, West DJ, Bracken RM.

Diabet Med. 2016 Apr;33(4):506-10. doi: 10.1111/dme.12870. Epub 2015 Aug 25.

PMID:
26220149
25.

Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.

Dunseath G, Ananieva-Jordanova R, Coles R, Powell M, Amoroso M, Furmaniak J, Smith BR, Dayan C, Luzio S.

Clin Chim Acta. 2015 Jul 20;447:90-5. doi: 10.1016/j.cca.2015.05.010. Epub 2015 May 22.

PMID:
26006309
26.

Similar magnitude of post-exercise hyperglycemia despite manipulating resistance exercise intensity in type 1 diabetes individuals.

Turner D, Gray BJ, Luzio S, Dunseath G, Bain SC, Hanley S, Richards A, Rhydderch DC, Ayles M, Kilduff LP, Campbell MD, West DJ, Bracken RM.

Scand J Med Sci Sports. 2016 Apr;26(4):404-12. doi: 10.1111/sms.12472. Epub 2015 Apr 28.

PMID:
25919405
27.

Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis.

Mallipedhi A, Prior SL, Dunseath G, Bracken RM, Barry J, Caplin S, Eyre N, Morgan J, Baxter JN, O'Sullivan SE, Sarmad S, Barrett DA, Bain SC, Luzio SD, Stephens JW.

J Diabetes Res. 2015;2015:680867. doi: 10.1155/2015/680867. Epub 2015 Mar 22.

28.

Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: results from a large Welsh national matched community cohort study.

Sayers A, Thayer D, Harvey JN, Luzio S, Atkinson MD, French R, Warner JT, Dayan CM, Wong SF, Gregory JW.

BMJ Open. 2015 Apr 13;5(4):e005644. doi: 10.1136/bmjopen-2014-005644.

29.

Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.

Thomas RL, Dunstan FD, Luzio SD, Chowdhury SR, North RV, Hale SL, Gibbins RL, Owens DR.

Br J Ophthalmol. 2015 Jan;99(1):64-8. doi: 10.1136/bjophthalmol-2013-304017. Epub 2014 Aug 4.

PMID:
25091950
30.

Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.

Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.

Hum Reprod. 2014 Sep;29(9):2041-9. doi: 10.1093/humrep/deu180. Epub 2014 Jul 17.

PMID:
25035436
31.

Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.

Manley SE, Hikin LJ, Round RA, Manning PW, Luzio SD, Dunseath GJ, Nightingale PG, Stratton IM, Cramb R, Sikaris KA, Gough SC, Webber J.

Diabetes Res Clin Pract. 2014 Sep;105(3):364-72. doi: 10.1016/j.diabres.2014.05.003. Epub 2014 May 23.

PMID:
24985893
32.

Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.

Campbell MD, Walker M, Trenell MI, Luzio S, Dunseath G, Tuner D, Bracken RM, Bain SC, Russell M, Stevenson EJ, West DJ.

PLoS One. 2014 May 23;9(5):e97143. doi: 10.1371/journal.pone.0097143. eCollection 2014.

33.

Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes.

Turner D, Luzio S, Kilduff LP, Gray BJ, Dunseath G, Bain SC, Campbell MD, West DJ, Bracken RM.

Diabet Med. 2014 Aug;31(8):1009-13. doi: 10.1111/dme.12462. Epub 2014 Apr 25.

PMID:
24702172
34.

Impact of single and multiple sets of resistance exercise in type 1 diabetes.

Turner D, Luzio S, Gray BJ, Dunseath G, Rees ED, Kilduff LP, Campbell MD, West DJ, Bain SC, Bracken RM.

Scand J Med Sci Sports. 2015 Feb;25(1):e99-109. doi: 10.1111/sms.12202. Epub 2014 Mar 20.

PMID:
24646137
35.

Effects of nutritional supplementation during pregnancy on early adult disease risk: follow up of offspring of participants in a randomised controlled trial investigating effects of supplementation on infant birth weight.

Macleod J, Tang L, Hobbs FD, Wharton B, Holder R, Hussain S, Nichols L, Stewart P, Clark P, Luzio S, Holly J, Smith GD.

PLoS One. 2013 Dec 13;8(12):e83371. doi: 10.1371/journal.pone.0083371. eCollection 2013.

36.

Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study.

Thomas RL, Prior SL, Barry JD, Luzio SD, Eyre N, Caplin S, Stephens JW, Owens DR.

J Diabetes Complications. 2014 Mar-Apr;28(2):191-5. doi: 10.1016/j.jdiacomp.2013.10.006. Epub 2013 Oct 23.

PMID:
24332764
37.

A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.

Luzio SD, Dunseath GJ, Atkinson MD, Owens DR.

Diabetes Metab. 2013 Dec;39(6):537-42. doi: 10.1016/j.diabet.2013.09.002. Epub 2013 Oct 17.

PMID:
24139704
38.

Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.

Peter R, Dunseath G, Luzio SD, Owens DR.

Diabetes Metab. 2013 Sep;39(4):337-42. doi: 10.1016/j.diabet.2013.07.001. Epub 2013 Aug 30.

PMID:
23993831
39.

Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa.

Thomas RL, Distiller L, Luzio SD, Chowdhury SR, Melville VJ, Kramer B, Owens DR.

Diabetes Care. 2013 Feb;36(2):336-41. doi: 10.2337/dc12-0683. Epub 2012 Oct 1.

40.

Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the "best method"?

Cassidy JP, Luzio SD, Marino MT, Baughman RA.

Clin Chem Lab Med. 2012 Jan 19;50(4):663-6. doi: 10.1515/cclm-2011-0860.

PMID:
22505557
41.

Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening.

Yeo ST, Edwards RT, Luzio SD, Charles JM, Thomas RL, Peters JM, Owens DR.

Diabet Med. 2012 Jul;29(7):878-85. doi: 10.1111/j.1464-5491.2012.03637.x.

PMID:
22414383
42.

Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment.

Yeo ST, Edwards RT, Fargher EA, Luzio SD, Thomas RL, Owens DR.

Diabet Med. 2012 Jul;29(7):869-77. doi: 10.1111/j.1464-5491.2012.03636.x.

PMID:
22414336
43.

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.

Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, North RV, Gibbins RL, Owens DR.

BMJ. 2012 Feb 22;344:e874. doi: 10.1136/bmj.e874.

44.

Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.

Stephens JW, Bodvarsdottir TB, Wareham K, Prior SL, Bracken RM, Lowe GD, Rumley A, Dunseath G, Luzio S, Deacon CF, Holst JJ, Bain SC.

Diabetes Res Clin Pract. 2011 Nov;94(2):199-206. doi: 10.1016/j.diabres.2011.07.014. Epub 2011 Aug 10.

PMID:
21835486
45.

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.

Owens DR, Luzio SD, Sert-Langeron C, Riddle MC.

Diabetes Obes Metab. 2011 Nov;13(11):1020-7. doi: 10.1111/j.1463-1326.2011.01459.x. Epub 2011 Sep 2.

46.

The effect of a supported exercise programme in patients with newly diagnosed Type 2 diabetes: a pilot study.

Backx K, McCann A, Wasley D, Dunseath G, Luzio S, Owens D.

J Sports Sci. 2011 Mar;29(6):579-86. doi: 10.1080/02640414.2010.544666.

PMID:
21347968
47.

Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes.

Bracken RM, West DJ, Stephens JW, Kilduff LP, Luzio S, Bain SC.

Diabet Med. 2011 Feb;28(2):218-22. doi: 10.1111/j.1464-5491.2010.03162.x.

PMID:
21219433
48.

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.

Bolli GB, Luzio S, Marzotti S, Porcellati F, Sert-Langeron C, Charbonnel B, Zair Y, Owens DR.

Diabetes Obes Metab. 2011 Mar;13(3):251-7. doi: 10.1111/j.1463-1326.2010.01343.x.

49.

A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus.

West DJ, Stephens JW, Bain SC, Kilduff LP, Luzio S, Still R, Bracken RM.

J Sports Sci. 2011 Feb;29(3):279-89. doi: 10.1080/02640414.2010.531753.

PMID:
21154013
50.

Exercise-induced hyperglycaemia in the absence of diabetes.

Bracken RM, Edavalath M, Morton R, West D, Fielding A, Luzio S, Underwood P, Stephens JW.

Diabet Med. 2010 Jun;27(6):723-4. doi: 10.1111/j.1464-5491.2010.02960.x. No abstract available.

PMID:
20546296

Supplemental Content

Support Center